UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A practical guide to selecting between total market and total world funds for retirement, focusing on goals, risk tolerance, and costs.
28,577 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
The United States and Europe are pursuing different routes to regulate AI, and the early market impact is clear—from ...
As Berkshire Hathaway's leadership evolves, investors wonder if berkshire hathaway greg abel has echoed Warren Buffet...
Palantir has been one of the most debated names in AI-driven analytics. This deep dive weighs the upside against the ...
When an IPO plunges, investors face a tough choice. This guide explains how to evaluate a stock that is down 84% and ...
Pi Network’s PI token fell about 30% within 24 hours after Kraken’s listing, renewing questions about the project’s r...
U.S. investors will soon access perpetual futures, a cornerstone of the hottest crypto products world, under a new re...
Micron stock losing ground sparks questions about memory cycles, AI-driven demand, and macro risks. This article brea...
Nuscale Power stock rocketing headlines point to optimism around small modular reactors, policy momentum, and utility...
Oil markets often move on how tight or loose inventories look. This guide explains why companies sounding alarm inven...
Could a SpaceX and Tesla merger reshape the future of tech and energy? This guide breaks down the potential benefits,...
A broad pullback in software stocks has created compelling opportunities for patient investors. Here are two names wi...